Literature DB >> 28456948

Advance Care Planning Communication: Oncology Patients and Providers Voice their Perspectives.

Jennifer L Bires1, Elizabeth F Franklin2, Helen M Nichols3, John G Cagle3.   

Abstract

Advance care planning helps to ensure that patients' end-of-life preferences are understood and discussed with providers. It is an important component of patient-centered care, particularly when patients are facing life-limiting illness. It also has ethical implications for providers, yet evidence suggests that these conversations are not always occurring, particularly in underserved populations. The aim of this study was to understand the challenges and personal beliefs regarding ACP through interviews with patients undergoing active cancer treatment and their oncology providers. This study took place at an urban, multispecialty cancer center in the mid-Atlantic region where approximately 1400 patients are treated each year. Findings revealed differences among both patients and providers in terms of their ACP knowledge, preferences, and practices. Overall, 70% of patients were familiar with advance directives (100% of White patients and 45.5% of Black patients), yet only 35% of them reported having completed one (55.6% of White patients and 18.2% of Black patients, although not statistically significant). Most providers (70%) held ACP conversations with patients with advanced illness only. They tended to make assumptions about the amount of information that patients desired and noted the significant challenges that were inherent with these types of conversations. Overall, ethical implications are inherent in ACP as patients are making medical decisions without always having necessary information. There are various reasons why providers may not supply information regarding potential outcomes and end-of-life planning and why patients may not request (or know to request) more medical information.

Entities:  

Keywords:  Advance care planning; End of life; Oncology

Mesh:

Year:  2018        PMID: 28456948     DOI: 10.1007/s13187-017-1225-4

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  12 in total

Review 1.  Current practices in advance care planning: implications for oncology nurses.

Authors:  Abigail Cohen; Anita Nirenberg
Journal:  Clin J Oncol Nurs       Date:  2011-10       Impact factor: 1.027

2.  The effect of race and ethnicity on outcomes among patients in the intensive care unit: a comprehensive study involving socioeconomic status and resuscitation preferences.

Authors:  Sara E Erickson; Eduard E Vasilevskis; Michael W Kuzniewicz; Brian A Cason; Rondall K Lane; Mitzi L Dean; Deborah J Rennie; R Adams Dudley
Journal:  Crit Care Med       Date:  2011-03       Impact factor: 7.598

3.  Aligning ethics with medical decision-making: the quest for informed patient choice.

Authors:  Benjamin Moulton; Jaime S King
Journal:  J Law Med Ethics       Date:  2010       Impact factor: 1.718

4.  American society of clinical oncology statement: toward individualized care for patients with advanced cancer.

Authors:  Jeffrey M Peppercorn; Thomas J Smith; Paul R Helft; David J Debono; Scott R Berry; Dana S Wollins; Daniel M Hayes; Jamie H Von Roenn; Lowell E Schnipper
Journal:  J Clin Oncol       Date:  2011-01-24       Impact factor: 44.544

5.  Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study.

Authors:  N A Christakis; E B Lamont
Journal:  BMJ       Date:  2000-02-19

6.  Patients' expectations about effects of chemotherapy for advanced cancer.

Authors:  Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

7.  Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.

Authors:  Alexi A Wright; Baohui Zhang; Alaka Ray; Jennifer W Mack; Elizabeth Trice; Tracy Balboni; Susan L Mitchell; Vicki A Jackson; Susan D Block; Paul K Maciejewski; Holly G Prigerson
Journal:  JAMA       Date:  2008-10-08       Impact factor: 56.272

8.  Racial and ethnic differences in advance care planning among patients with cancer: impact of terminal illness acknowledgment, religiousness, and treatment preferences.

Authors:  Alexander K Smith; Ellen P McCarthy; Elizabeth Paulk; Tracy A Balboni; Paul K Maciejewski; Susan D Block; Holly G Prigerson
Journal:  J Clin Oncol       Date:  2008-09-01       Impact factor: 44.544

Review 9.  Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review.

Authors:  Karen Hancock; Josephine M Clayton; Sharon M Parker; Sharon Wal der; Phyllis N Butow; Sue Carrick; David Currow; Davina Ghersi; Paul Glare; Rebecca Hagerty; Martin H N Tattersall
Journal:  Palliat Med       Date:  2007-09       Impact factor: 4.762

10.  Discussions of Life Expectancy and Changes in Illness Understanding in Patients With Advanced Cancer.

Authors:  Andrew S Epstein; Holly G Prigerson; Eileen M O'Reilly; Paul K Maciejewski
Journal:  J Clin Oncol       Date:  2016-05-23       Impact factor: 44.544

View more
  3 in total

1.  End-of-life decision making in the context of chronic life-limiting disease: a concept analysis and conceptual model.

Authors:  Kristin Levoy; Elise C Tarbi; Joseph P De Santis
Journal:  Nurs Outlook       Date:  2020-09-15       Impact factor: 3.250

Review 2.  A model for the uptake of advance care planning in older cancer adults: a scoping review.

Authors:  Yiping Chen; Liyuan Hou; Xianhui Zhang; Yifei Du; Xiaoqing Zhang; Min Li; Chaoyue Gao; Hui Yang
Journal:  Aging Clin Exp Res       Date:  2022-07-26       Impact factor: 4.481

3.  Interdisciplinary staff perceptions of advance care planning in long-term care homes: a qualitative study.

Authors:  Shirin Vellani; Elizabeth Green; Pereya Kulasegaram; Tamara Sussman; Abby Wickson-Griffiths; Sharon Kaasalainen
Journal:  BMC Palliat Care       Date:  2022-07-15       Impact factor: 3.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.